EPIC Cosmos analysis of dupilumab utilization and access disparities in atopic dermatitis
Journal of the American Academy of Dermatology · 2026-08 · 95 (2) · 505-507
DOI: 10.1016/j.jaad.2026.04.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Mihir M Shah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University School of Medicine, Stanford, California. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford University School of Medicine, Stanford, California.
- Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
- Department of Dermatology, Stanford University School of Medicine, Redwood City, California. Electronic address: gbae@stanford.edu.
Zitieren
APA
Shah, M. M., Pour Mohammad, A., Ko, J. M., & Bae, G. H. (2026). EPIC Cosmos analysis of dupilumab utilization and access disparities in atopic dermatitis. Journal of the American Academy of Dermatology, 95(2), 505-507. https://doi.org/10.1016/j.jaad.2026.04.007
Vancouver
Shah MM, Pour Mohammad A, Ko JM, Bae GH. EPIC Cosmos analysis of dupilumab utilization and access disparities in atopic dermatitis. Journal of the American Academy of Dermatology. 2026;95(2):505-507. doi:10.1016/j.jaad.2026.04.007
BibTeX
@article{Shah2026,
author = {Shah, Mihir M and Pour Mohammad, Arash and Ko, Justin M and Bae, Gordon H},
title = {EPIC Cosmos analysis of dupilumab utilization and access disparities in atopic dermatitis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {2},
pages = {505--507},
doi = {10.1016/j.jaad.2026.04.007}
}
EUVIMED